A detailed history of Centric Wealth Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Centric Wealth Management holds 4,089 shares of BMY stock, worth $222,114. This represents 0.05% of its overall portfolio holdings.

Number of Shares
4,089
Holding current value
$222,114
% of portfolio
0.05%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$40.25 - $52.99 $164,582 - $216,676
4,089 New
4,089 $169,000
Q2 2021

Jul 21, 2021

SELL
$61.91 - $67.42 $3 Million - $3.27 Million
-48,458 Closed
0 $0
Q1 2021

Apr 14, 2021

BUY
$59.34 - $66.74 $2.51 Million - $2.83 Million
42,334 Added 691.28%
48,458 $3.06 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $39,378 - $44,623
682 Added 12.53%
6,124 $380,000
Q3 2020

Oct 05, 2020

SELL
$57.43 - $63.64 $20,387 - $22,592
-355 Reduced 6.12%
5,442 $268,000
Q2 2020

Jul 29, 2020

BUY
$54.82 - $64.09 $19,461 - $22,751
355 Added 6.52%
5,797 $341,000
Q1 2020

Apr 08, 2020

SELL
$46.4 - $67.43 $4,964 - $7,215
-107 Reduced 1.93%
5,442 $268,000
Q4 2019

Jan 06, 2020

BUY
$49.21 - $64.19 $5,265 - $6,868
107 Added 1.97%
5,549 $356,000
Q3 2019

Oct 03, 2019

BUY
$42.77 - $50.71 $232,754 - $275,963
5,442 New
5,442 $268,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Centric Wealth Management Portfolio

Follow Centric Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centric Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Centric Wealth Management with notifications on news.